Axis-Shield awarded Japanese Afinion patent

Scottish-Norwegian in vitro diagnostics firm Axis-Shield has received notice of approval for its Japanese patent application governing the measuring methodology for HbA1c within the Afinion cassette for detection of the marker of diabetic patient compliance.

The firm says the patent protects technology which improves HbA1c stability, precision and accuracy and has resulted in a longer product shelf-life with improved performance.

Ian Gilham, chief executive, said: "global IP protection for Afinion and the test menu is very important to us, particularly now this best-in-class point-of-care analyser and the HbA1c test are becoming more established as the ease-of-use and reliability of the Afinion system are demonstrated."